Employer record · Bronx, NY · FY2020–FY2026

Ny Drugs, Inc.

    USCIS approval rateFY24–26 · 4 approved

    Certified LCAs
    4
    FY2024–FY2026
    USCIS approvals
    4
    2 new employment
    Denial rate
    20.0%
    FY2024–FY2026
    Median wage offered
    $94k
    certified LCAs

    Jobs not indexed yet

    Does Ny Drugs, Inc. sponsor H-1B visas?

    Yes — by its record, Ny Drugs, Inc. is a small-scale H-1B sponsor: it filed 4 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 4 USCIS H-1B petition approvals (2 for new employment). Its latest certified LCA in our data was decided Apr 22, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep) — 12 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Ny Drugs, Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2021100%
    FY2132100%
    FY2331100%
    FY241150%
    FY2633100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Regulatory Affairs Specialists 13-10413$89k
    Pharmacists 29-10511$152k

    Most-filed job titles

    1. SR. REGULATORY AND COMPLIANCE ANALYST2$85k
    2. Pharmacist1$152k
    3. Quality Assurance and Compliance Strategist1$98k

    LCAs per title and median wage offered.

    Where the jobs were

    1. New York4 LCAs

    We haven't indexed Ny Drugs' jobs yet

    We read jobs straight from employers' own career sites and haven't added Ny Drugs' yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • CASTLE HILL COMMUNITY PHARMACY (d/b/a)
    • NY DRUGS INC DBA CASTLE HILL COMMUNITY PHARMACY (USCIS)
    • NY DRUGS, INC. (LCA)
    • NY DRUGS INC DBA CASTLE HILL COMMU (USCIS)
    • NY DRUGS INC DBA CASTLE HILL (USCIS)
    • NY DRUGS INC DBA CASTLE HILL COMTY (USCIS)

    Ny Drugs, Inc. H-1B: questions people ask

    Does Ny Drugs, Inc. sponsor H-1B visas?

    Yes — by its record, Ny Drugs, Inc. is a small-scale H-1B sponsor: it filed 4 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 4 USCIS H-1B petition approvals (2 for new employment). Its latest certified LCA in our data was decided Apr 22, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Ny Drugs, Inc. still sponsoring H-1B in 2026?

    Ny Drugs, Inc. had 3 certified LCAs in FY2026 (Oct 2025–Sep 2026), more than the 0 in FY2025. The latest one in our data was decided Apr 22, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Ny Drugs, Inc. get approved?

    USCIS recorded 4 approvals (2 for new employment, the rest continuing employment such as extensions and transfers) and 1 denials for Ny Drugs, Inc. in FY2024–FY2026 — a denial rate of 20.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Ny Drugs, Inc.?

    The median wage offered on Ny Drugs, Inc.'s certified LCAs in FY2024–FY2026 was $94k a year. By job title: SR. REGULATORY AND COMPLIANCE ANALYST $85k (2 LCAs), Pharmacist $152k (1 LCAs) and Quality Assurance and Compliance Strategist $98k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Ny Drugs, Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Regulatory Affairs Specialists (3) and Pharmacists (1).

    Where are Ny Drugs, Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): New York (4).

    Is Ny Drugs, Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Ny Drugs, Inc. have open jobs?

    We read jobs straight from employers' own career sites and haven't added Ny Drugs' yet.